Because the R248W SNP is described to impair IDO2 catalytic activity and the Y359X SNP generates a premature stop codon abolishing activity completely (26), the link observed between both SNPs and the development of NSCLC would support a relevant contribution of a defective enzymatic activity of IDO2 to disease pathogenesis. This evidence concerns the gene IDO2 and non-small cell lung carcinoma.